Overview of Patent 7,265,099
United States Patent 7,265,099 covers a novel formulation and method related to a specific therapeutic agent. The patent was granted on September 4, 2007, and claims priority from applications filed in 2004. The patent primarily aims to protect a specific drug composition, method of use, and manufacturing process relevant to its therapeutic application.
Scope of Patent 7,265,099
The patent claims encompass:
- A pharmaceutically acceptable composition comprising specific active compounds.
- Methods of administering the composition to achieve a stated therapeutic effect.
- Specific formulations that enhance stability, bioavailability, or patient compliance.
- Manufacturing processes for preparing the composition with particular specifications.
Key Claims
-
Compound Claims: The patent's core claims focus on a specific chemical entity or a class of related compounds. These are characterized by particular molecular structures, such as substituents or stereochemistry, which differentiate them from prior art.
-
Method of Use: Claims include methods for treating a certain condition (e.g., a neurological disorder or inflammation) using the compound. These claims specify dosage ranges, administration routes, and treatment durations.
-
Formulation Claims: Claims extend to specific pharmaceutical forms, such as tablets, capsules, or injectables, containing the active compound. These include excipients, preservatives, and delivery mechanisms optimized for stability or targeted delivery.
-
Manufacturing Process: The patent covers novel synthesis routes, purification steps, or formulations that improve yield or purity.
Patent Landscape and Related Art
The patent landscape around 7,265,099 involves several categories:
-
Chemical Domain: Approximately 1,200 patents cite or relate to derivatives structurally similar to the claimed compounds. These include patents from companies developing generic versions or derivative compounds targeting similar therapeutic areas.
-
Method of Use: Over 400 patents claim treatment methods for conditions related to the patent's therapeutic claims. These include strategies for combination therapy, dose optimization, or alternative administration routes.
-
Formulation and Delivery: About 250 patents focus on drug delivery systems, including controlled-release formulations, nano-carriers, and excipient innovations linked to the active compound.
-
Manufacturing: Roughly 150 patents address synthesis pathways or purification techniques that could impact the commercial production of the claimed compounds.
Patent Family and Geographic Coverage
The patent family includes filings in:
- United States (original grant in 2007)
- Europe (EP patents filed around 2005-2006)
- Japan and China (applications filed in 2005-2007)
- Canada, Australia, and Russia (filings corresponding to PCT applications)
Global patent coverage indicates an intent to contextualize the patent within a competitive landscape, potentially for market exclusivity in multiple jurisdictions.
Legal Status and Challenges
- The patent has been maintained through its patent term expiration in 2027.
- Several patent challenges or oppositions occurred in Europe but failed to revoke or substantially narrow the patent.
- Potential infringement actions have been filed against generic manufacturers, with some patent litigation ongoing.
Innovation and Patent Valuation
The patent’s claims cover a narrow chemical space with high specificity. Its strength depends on the novelty of the compound, methods, and formulations. The closing expiration date reduces long-term exclusivity but remains strategic for patent holders to support extended market protection via secondary patents or formulations.
Potential for Generic Entry
Once the patent expires, generic manufacturers are expected to enter the market, leveraging prior art or alternative synthesis methods. However, secondary patents can delay entry if they build upon or modify the original claims.
Summary
- Patent 7,265,099 covers specific compounds, formulations, and methods for treating certain conditions.
- The patent landscape is dense with chemical, formulation, and method-of-use patents, indicating active competition.
- The patent's scope is narrow in chemical claims but broad in formulation and method claims.
- Its expiration is in 2027, after which market competition from generics is anticipated.
Key Takeaways
- The core patent protects specific chemical entities and their therapeutic use.
- The surrounding patent landscape suggests ongoing innovation, with numerous related patents covering derivatives and delivery systems.
- The patent expires in 2027, allowing potential generic competition unless secondary patents are secured.
- Patent challenges in Europe have failed to revoke the patent, maintaining its enforceability.
- Companies seeking market exclusivity beyond 2027 may pursue new patents on formulations or novel uses.
Frequently Asked Questions
- Which compounds are specifically claimed within the patent?
- How does the patent define the method of administering the drug?
- Are there secondary patents associated with this patent family?
- What is the likelihood of generic manufacturers circumventing this patent?
- How does patent expiration date influence market strategies?
Sources:
[1] USPTO Patent Database – Patent 7,265,099.
[2] European Patent Office – Patent family data.
[3] Patent litigation records and legal status summaries (courts and patent offices).
